Cancer is characterized by genetic mutations and epigenetic modifications that alter normal cellular processes. These changes can affect various signaling pathways and networks, making them hyperactive, inactive, or entirely re-wired. For instance, mutations in the PI3K/Akt/mTOR pathway can lead to increased cell survival and growth.
